相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Secular Trends of Hospitalization With Vancomycin-Resistant Enterococcus Infection in the United States, 2000-2006
Andrew M. Ramsey et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study
Jean Chastre et al.
CRITICAL CARE MEDICINE (2008)
Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000-2005
Marya D. Zilberberg et al.
EMERGING INFECTIOUS DISEASES (2008)
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005
Eili Klein et al.
EMERGING INFECTIOUS DISEASES (2007)
Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit
Lisa S. Young et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
Scott T. Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
I. I. Siempos et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC)
H. Leblebicioglu et al.
JOURNAL OF HOSPITAL INFECTION (2007)
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial
Samir G. Sakka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The business of developing antibacterials
Jeffrey L. Fox
NATURE BIOTECHNOLOGY (2006)
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia
E. J. Giamarellos-Bourboulis et al.
JOURNAL OF CHEMOTHERAPY (2006)
Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections
Mireia Saballs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia - a double blind prospective multicentre study
D. V. Schmitt et al.
INFECTION (2006)
Pneumonia due to Pseudomonas aeruginosa:: the levofloxacin clinical trials experience
Alan M. Tennenberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
Francisco Alvarez-Lerma et al.
CRITICAL CARE (2006)
Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
V Aloush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia
Katsunori Yanagihara et al.
INTERNAL MEDICINE (2006)
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia
Maniari Joshi et al.
RESPIRATORY MEDICINE (2006)
Levofloxacin for treatment of ventilator-associated pneumonia: Putting the cart before the horse - Response
AF Shorr et al.
CLINICAL INFECTIOUS DISEASES (2005)
Pseudomonas aeruginosa bloodstream infection:: Importance of appropriate initial antimicrobial treatment
ST Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Quinolones for treatment of nosocomial pneumonia: A meta-analysis
AF Shorr et al.
CLINICAL INFECTIOUS DISEASES (2005)
National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002
MD Obritsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Trends in antimicrobial drug development: Implications for the future
B Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2004)
Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients -: A multicenter study of 67 cases
M Torres-Tortosa et al.
CHEST (2003)
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study
M West et al.
CLINICAL THERAPEUTICS (2003)
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: A multicenter, evaluator-blind, prospective, randomized study
G Zanetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Carbapenems in the treatment of severe community acquired pneumonia in hospitalized elderly patients: A comparative study against standard therapy
G Romanelli et al.
JOURNAL OF CHEMOTHERAPY (2002)
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000)
AC Gales et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
Colistin: An antimicrobial for the 21st century?
A Stein et al.
CLINICAL INFECTIOUS DISEASES (2002)
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia
M Iregui et al.
CHEST (2002)
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia
B Maskin et al.
CRITICAL CARE MEDICINE (2002)
Characterization of Pseudomonas aeruginosa isolates:: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999
AC Gales et al.
CLINICAL INFECTIOUS DISEASES (2001)
An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia
C Feldman et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Treatment of severe nosocomial pneumonia:: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin
A Torres et al.
THORAX (2000)
In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998
H Bello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation
G Egerer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
分享论文
